Efficacy of Pharmacological Interventions for Depression Post-Traumatic Brain Injury

AI Summary

Depression after TBI is responsive to pharmacological interventions in at least some individuals, but no specific drug or class is recommended.
Multimodal treatment combining pharmacotherapy, evidence-based psychological therapies and lifestyle interventions may be most valuable with measurement-based care monitoring effectiveness.
Randomised controlled trials comparing drugs are needed; methylphenidate and sertraline are proposed as top-priority candidates.

TL;DR (AI Generated)

Considering the pooled evidence, this article concludes that depression after TBI is responsive to pharmacological interventions in at least some individuals but abstains from recommending a specific drug or drug class.

Multimodal treatments, combining pharmacotherapy with evidence-based psychological therapies and lifestyle interventions, may be most valuable with measurement-based care used to monitor treatment effectiveness.

Basic summary

Phys Med Rehabil Clin N Am. 2027 Feb;38(1):121-140. doi: 10.1016/j.pmr.2026.08.007. Epub 2026 Sep 11.

ABSTRACT

This article summarizes the conclusions and recommendations from 7 reviews and clinical guidelines up to February 2026 examining pharmacological treatments for depression in those with traumatic brain injury (TBI). Considering the pooled evidence, this article concludes that depression after TBI is responsive to pharmacological interventions in at least some individuals but abstains from recommending a specific drug or drug class. Multimodal treatments, combining pharmacotherapy with evidence-based psychological therapies and lifestyle interventions, may be most valuable with measurement-based care used to monitor treatment effectiveness. Randomized controlled trials are needed that conduct drug comparisons, with methylphenidate and sertraline suggested as top-priority candidates.

PMID:43025913 | DOI:10.1016/j.pmr.2026.08.007

Document this CPD